Search This Blog

Wednesday, August 5, 2026

BioCryst beats, ups guidance

 

BioCryst beats Q2 estimates with net income $78.4M, EPS $0.30, revenue $218.3M, raises 2026 revenue guidance to $690–$715M

  • BioCryst reported Q2 2026 operating profit of $98.5M on revenue of $218.3M.
  • 2026 ORLADEYO revenue guidance maintained at $625–$645M within updated total company revenue outlook.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)